Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Akebia Therapeutics Inc. market cap is $276.37M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Akebia Therapeutics Inc. 52 week high is $2.48 as of April 30, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Akebia Therapeutics Inc. 52 week low is $0.7801 as of April 30, 2024.
Akebia Therapeutics Inc. stock price today is $1.26.
Akebia Therapeutics Inc. stock price yesterday was $1.32.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Akebia Therapeutics Inc.’s P/E ratio is -4.79.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Akebia Therapeutics Inc. P/B ratio is -8.3980.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Akebia Therapeutics Inc.'s EBITDA is -34.03.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Akebia Therapeutics Inc. 50-day moving average is $1.57.
Akebia Therapeutics Inc. has 167 employees.